142 related articles for article (PubMed ID: 1587967)
1. Comparative investigation of the influence of nizatidine, ranitidine, and cimetidine on the steady-state pharmacokinetics of theophylline in COPD patients.
Bachmann K; Sullivan TJ; Mauro LS; Martin M; Jauregui L; Levine L
J Clin Pharmacol; 1992 May; 32(5):476-82. PubMed ID: 1587967
[TBL] [Abstract][Full Text] [Related]
2. Drug interactions of H2-receptor antagonists.
Bachmann KA; Sullivan TJ; Jauregui L; Reese J; Miller K; Levine L
Scand J Gastroenterol Suppl; 1994; 206():14-9. PubMed ID: 7863246
[TBL] [Abstract][Full Text] [Related]
3. Effect of cimetidine and ranitidine on plasma theophylline in patients with chronic obstructive airways disease treated with theophylline and corticosteroids.
Boehning W
Eur J Clin Pharmacol; 1990; 38(1):43-5. PubMed ID: 2328746
[TBL] [Abstract][Full Text] [Related]
4. Effects of cimetidine and ranitidine on the pharmacokinetics of a chronotherapeutically formulated once-daily theophylline preparation (Uniphyl).
Fraser IM; Buttoo KM; Walker SE; Stewart JH; Babul N
Clin Ther; 1993; 15(2):383-93. PubMed ID: 8519046
[TBL] [Abstract][Full Text] [Related]
5. The effects of once-daily dosing with ranitidine and cimetidine on theophylline pharmacokinetics.
McEwen J; McMurdo ME; Moreland TA
Eur J Drug Metab Pharmacokinet; 1988; 13(3):201-5. PubMed ID: 3240766
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of theophylline and the H2-antagonist drugs cimetidine and ranitidine.
Dal Negro R; Pomari C; Zoccatelli O; Trevisan F; Carloni C; Turco P
Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):221-6. PubMed ID: 6325354
[TBL] [Abstract][Full Text] [Related]
7. H2-antagonist derangement of the kinetics of sustained-release oral theophylline.
Dal Negro R; Turco P; Zoccatelli O; Trevisan F; Pomart C
Int J Clin Pharmacol Ther Toxicol; 1985 Jun; 23(6):329-32. PubMed ID: 2862112
[TBL] [Abstract][Full Text] [Related]
8. Steady-state pharmacokinetics of theophylline in COPD patients treated with dirithromycin.
Bachmann K; Jauregui L; Sides G; Sullivan TJ
J Clin Pharmacol; 1993 Sep; 33(9):861-5. PubMed ID: 8227485
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of theophylline clearance by cimetidine but not ranitidine.
Powell JR; Rogers JF; Wargin WA; Cross RE; Eshelman FN
Arch Intern Med; 1984 Mar; 144(3):484-6. PubMed ID: 6322709
[TBL] [Abstract][Full Text] [Related]
10. Effects of successive doses of nizatidine, cimetidine and ranitidine on serum gastrin level and gastric acid secretion.
Yamaji Y; Omata T; Abe T; Yoshida A; Ueki S; Aita H; Morita H; Chaki K; Segawa Y; Kurimoto T
Arzneimittelforschung; 1991 Sep; 41(9):954-7. PubMed ID: 1796924
[TBL] [Abstract][Full Text] [Related]
11. Effects of equimolar doses of cimetidine and ranitidine on theophylline elimination.
Adebayo GI
Biopharm Drug Dispos; 1989; 10(1):77-85. PubMed ID: 2923963
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of the H2-receptor antagonists cimetidine, ranitidine, famotidine and nizatidine on the rabbit stomach fundus and sigmoid colon.
Kounenis G; Koutsoviti-Papadopoulou M; Elezoglou A; Voutsas A
J Pharmacobiodyn; 1992 Oct; 15(10):561-5. PubMed ID: 1362967
[TBL] [Abstract][Full Text] [Related]
13. [Effect of ranitidine on the pharmacokinetics of theophylline in patients with obstructive pulmonary disease].
Paranos S; Despotović N; Vidanović M; Bojović I; Milovanović M; Dmitrović V; Bozović M
Glas Srp Akad Nauka Med; 1991; (41):45-52. PubMed ID: 1916446
[TBL] [Abstract][Full Text] [Related]
14. Controlled study of the putative interaction between famotidine and theophylline in patients with chronic obstructive pulmonary disease.
Bachmann K; Sullivan TJ; Reese JH; Jauregui L; Miller K; Scott M; Yeh KC; Stepanavage M; King JD; Schwartz J
J Clin Pharmacol; 1995 May; 35(5):529-35. PubMed ID: 7657856
[TBL] [Abstract][Full Text] [Related]
15. Famotidine effects on theophylline pharmacokinetics in subjects affected by COPD. Comparison with cimetidine and placebo.
Verdiani P; Di Carlo S; Baronti A
Chest; 1988 Oct; 94(4):807-10. PubMed ID: 3168576
[TBL] [Abstract][Full Text] [Related]
16. Effects of H2-receptor antagonists on gastric alcohol dehydrogenase activity.
Caballería J; Baraona E; Deulofeu R; Hernández-Muñoz R; Rodés J; Lieber CS
Dig Dis Sci; 1991 Dec; 36(12):1673-9. PubMed ID: 1684149
[TBL] [Abstract][Full Text] [Related]
17. Famotidine and theophylline pharmacokinetics. An unexpected cimetidine-like interaction in patients with chronic obstructive pulmonary disease.
Dal Negro R; Pomari C; Turco P
Clin Pharmacokinet; 1993 Mar; 24(3):255-8. PubMed ID: 8462230
[TBL] [Abstract][Full Text] [Related]
18. Interaction of steady-state procainamide with H2-receptor antagonists cimetidine and ranitidine.
Rodvold KA; Paloucek FP; Jung D; Gallastegui J
Ther Drug Monit; 1987 Dec; 9(4):378-83. PubMed ID: 2447687
[TBL] [Abstract][Full Text] [Related]
19. Cimetidine inhibits theophylline clearance in patients with chronic obstructive pulmonary disease: a study using stable isotope methodology during multiple oral dose administration.
Vestal RE; Thummel KE; Musser B; Mercer GD
Br J Clin Pharmacol; 1983 Apr; 15(4):411-8. PubMed ID: 6849776
[TBL] [Abstract][Full Text] [Related]
20. Effect of H2-receptor antagonists on steady-state extraction of indocyanine green and lidocaine by the perfused rat liver.
Roberts RK; Heath CA; Johnson RF; Speeg KV; Schenker S
J Lab Clin Med; 1986 Feb; 107(2):112-7. PubMed ID: 2868064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
